-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Raises Price Target to $45

Benzinga·02/17/2026 11:51:11
Listen to the news
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Tyra Biosciences (NASDAQ:TYRA) with a Buy and raises the price target from $30 to $45.